cetylpyridinium chloride anhydrous and pevonedistat

cetylpyridinium chloride anhydrous has been researched along with pevonedistat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Hu, Z; Huang, J; Jia, L; Li, B; Li, J; Mao, F; Ni, S; Sun, Y; Xu, Y; Yang, X; Yu, Q; Zhang, J; Zhang, W	1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and pevonedistat

Article	Year
Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth. European journal of medicinal chemistry, 2020, Jan-01, Volume: 185 Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Tetrazoles	2020

Article

Year

Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth.

European journal of medicinal chemistry, 2020, Jan-01, Volume: 185

Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Tetrazoles

2020